Yes. Surface Oncology was formerly owned by 1 private investor.
Surface Oncology is headquartered in Cambridge, Massachusetts.
Surface Oncology disclosed revenue of 30M USD for 2022 and 3M USD for 2021.
Surface Oncology is a life science company.
Surface Oncology was founded in 2014.
50 Hampshire Street, 8th Floor,
Cambridge, Massachusetts
02139
United States,
(617) 714-4096
www.surfaceoncology.com
Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned programs: SRF388, a Phase 2 program targeting IL-27, and SRF114, a Phase 1 program that selectively depletes regulatory T cells in the tumor microenvironment via targeting CCR8. Surface Oncology was founded in 2014 and is based in Cambridge, Massachusetts.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
